EMEL
EMEL has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €185k and a net result of €34k. Equity is growing by ~16.2% per year across the filed fiscal years. Its solvency ranks better than 69% of 2224 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
| Equity | €185k |
| Net result | €34k |
| Better than sector | 69% |
| Active | 22 yrs |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 78.2% | 57.9% | |
| Net result | €34k | €59k | |
| Equity | €185k | €74k | |
| Gross operating margin | €75k | €95k | |
| Total assets | €237k | €187k |
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - |
| EBITDA | €64k | €79k | €34k | €42k |
| Net profit | €34k | €45k | €12k | €18k |
| Cash flow | €49k | €59k | €26k | €31k |
| Staff costs | - | - | - | - |
| Income taxes | €14k | €18k | €6k | €8k |
| Dividends | - | €23k | €7k | €6k |
| Total assets | €237k | €218k | €203k | €217k |
| Equity | €185k | €151k | €128k | €123k |
| Debt | €52k | €67k | €74k | €94k |
| of which ≤ 1y | €37k | €41k | €36k | €37k |
| of which > 1y | €14k | €26k | €38k | €57k |
| Working capital | €19k | €22k | €-1k | €-1k |
| Employees (FTE) | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Current ratio | 1.50 | 1.53 | 0.97 | 0.97 |
| Quick ratio | 1.50 | 1.53 | 0.97 | 0.97 |
| Working capital ratio | 7.9% | 9.9% | -0.5% | -0.6% |
| Solvency | 78.2% | 69.2% | 63.3% | 56.6% |
| Debt / equity | 0.28 | 0.44 | 0.58 | 0.77 |
| Long-term debt ratio | 0.08 | 0.17 | 0.30 | 0.46 |
| Interest coverage | 45.12 | 49.82 | 18.21 | 16.44 |
| Gross margin | - | - | - | - |
| Net margin | - | - | - | - |
| ROA | 14.5% | 20.8% | 6.1% | 8.1% |
| ROE | 18.5% | 30.0% | 9.7% | 14.3% |
| EBITDA margin | - | - | - | - |
| Days sales outstanding | - | - | - | - |
| Days payable outstanding | - | - | - | - |
| Inventory turnover | - | - | - | - |
| Days inventory (DSI) | - | - | - | - |
Full annual accounts (23 line items)
| Line item | Code | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Balance sheet, Assets | |||||
| TOTAL ASSETS | 20/58 | €237k | €218k | €203k | €217k |
| Fixed assets | 21/28 | €181k | €155k | €167k | €181k |
| Tangible fixed assets | 22/27 | €180k | €155k | €167k | €181k |
| Financial fixed assets | 28 | €860 | €110 | €110 | €110 |
| Current assets | 29/58 | €56k | €63k | €35k | €36k |
| Amounts receivable within one year | 40/41 | €46k | €38k | €30k | €33k |
| Cash & bank | 54/58 | €8k | €22k | €4k | €1k |
| Balance sheet, Equity & liabilities | |||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €237k | €218k | €203k | €217k |
| Equity | 10/15 | €185k | €151k | €128k | €123k |
| Contributions / capital | 10/11 | €36k | €36k | €36k | €36k |
| Reserves | 13 | €149k | €115k | €92k | €86k |
| Amounts payable | 17/49 | €52k | €67k | €74k | €94k |
| Amounts payable after one year | 17 | €14k | €26k | €38k | €57k |
| Amounts payable within one year | 42/48 | €37k | €41k | €36k | €37k |
| Trade debts payable within one year | 44 | €15k | €3k | €8k | €5k |
| Income statement | |||||
| Gross operating margin | 9900 | €75k | €83k | €38k | €47k |
| Operating result | 9901 | €50k | €65k | €20k | €29k |
| Financial income | 75 | €0 | €172 | €2 | €10 |
| Financial charges | 65 | €1k | €2k | €2k | €3k |
| Result before taxes | 9903 | €48k | €64k | €18k | €26k |
| Income taxes | 67/77 | €14k | €18k | €6k | €8k |
| Net result for the period | 9904 | €34k | €45k | €12k | €18k |
| Result to be appropriated | 9905 | €34k | €45k | €12k | €18k |
-
Michèle LEJEUNEDirectorState Gazette act 24435098 (09-10-2024)Current09-10-2024 → present
| NACE primary | Specialist medical practice(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 11-12-2003 |
| Status | Active |
| Postal code | 1050 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21447B0298/00S013 | Brussels | 9,346 m² | 1 · 205 m² | 16.1 m · 4 fl. |
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
09-10-2024 Michèle LEJEUNE appointed as director
- Michèle LEJEUNE, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Mich\u00E8le LEJEUNE",
"address": "Ixelles (1050 Bruxelles), rue Africaine 1/3",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": null,
"statutory": "statutair",
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "g\u00E9rant",
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "vaste_vertegenwoordiger",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0542.781.118",
"name": "FINANCE \u0026 TAX",
"address": "5100 Namur, chauss\u00E9e de Marche 727b",
"country": "BE",
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Jean-Pierre MARCHANT",
"firm_city": null,
"firm_name": null,
"office_city": "Uccle",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-10-09",
"filing_date": "2024-10-07",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2024-09-27",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0862.143.225",
"name_full": "EMEL",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Jean-Pierre MARCHANT",
"org_rep_person_name": null,
"person_role_at_subject": "notaire"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}| Legal nameFR | EMEL |